Sign In
Buy INSP
$41.75
+0.400 (+0.97%)
At Close: Jun 23, 2026
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026
11:31am, Monday, 22'nd Jun 2026
Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
08:00am, Tuesday, 16'th Jun 2026
Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
08:00am, Friday, 12'th Jun 2026
MINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
11:49am, Thursday, 11'th Jun 2026
Alphatec bets on integrated spine surgery tech, while Inspire leads in sleep apnea devices with robust profitability. How do their financials and risks stack up?
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff
05:08am, Monday, 08'th Jun 2026
Inspire Medical Systems faces a sharp revenue slowdown due to temporary CPT coding and CMS Project WISeR disruptions, not fundamental business weakness. INSP maintains a robust balance sheet with ~$40
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?
12:30pm, Wednesday, 03'rd Jun 2026
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript
05:10pm, Wednesday, 13'th May 2026
Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip
05:59pm, Tuesday, 05'th May 2026
Inspire Medical Systems, Inc. remains under pressure as Q1 revenue grew just 1.6% and management slashed 2026 guidance by up to 10%. INSP faces intensifying competition from GLP-1s and rival devices,
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down
12:50pm, Tuesday, 05'th May 2026
INSP beats Q1 estimates but slashes 2026 outlook as reimbursement disruptions and WISeR program weigh on growth and procedure volumes.
Pre-Market Stock Futures: Futures are trading higher on Tuesday after new highs on Friday turned into a risk-off Monday, triggered by rising oil prices, a report that Iran attacked the UAE, and an add
Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript
07:43pm, Monday, 04'th May 2026
Inspire Medical Systems, Inc. (INSP) Q1 2026 Earnings Call Transcript
Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say
07:01pm, Monday, 04'th May 2026
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street
Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates
06:50pm, Monday, 04'th May 2026
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of a loss of $0.36 per share. This compares to earnings of $0.1 per share a year
Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance
04:02pm, Monday, 04'th May 2026
MINNEAPOLIS, May 04, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire, or the Company), a medical technology company focused on the development and commercialization of inn
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
08:00am, Wednesday, 29'th Apr 2026
MINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minim
